Schedule 13G ownership disclosure

APPLIED THERAPEUTICS INC

Common Stock · CUSIP: 03828A101

Event date: 2025-01-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 2,858,931 · Class: 2.5%

  • Morgan Stanley Capital Services LLC

    Shares: 2,667,759 · Class: 2.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000266
Form type
SCHEDULE 13G/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Feb 07, 2025
Reporting period
Jan 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub